Jennifer Riter

DDL has appointed Jennifer Riter as Vice President of Analytical Testing Services, strengthening its leadership team and expanding its Good Manufacturing Practice (GMP) testing and drug-device combination product consulting capabilities.

In her new role, Riter will lead DDL's analytical testing services while providing expert guidance on primary container closure system strategies, filling and sealing processes, and the development of new GMP laboratory capabilities, including USP 1207 deterministic Container Closure Integrity testing. Her appointment supports the company's continued investment in regulatory-compliant analytical services for the pharmaceutical, biotechnology, and medical device industries.

Riter brings nearly 30 years of leadership experience in analytical testing, technical operations, and business strategy across the pharmaceutical and drug delivery sectors. Most recently, she served as Vice President of Analytical and Development Services at Kindeva Drug Delivery, where she led global analytical and development organizations and played a key role in expanding the company's analytical testing capabilities.

Before joining Kindeva, Riter spent nearly three decades at West Pharmaceutical Services, holding a variety of senior leadership positions across analytical services, business operations, sales, and strategic growth. Throughout her career, she has successfully built high-performing teams, introduced new analytical service offerings, and enhanced operational excellence to support pharmaceutical customers worldwide.

Riter's appointment further strengthens DDL's capabilities at its FDA-registered analytical laboratory in Minnetonka, Minnesota, which provides GMP testing, ICH stability studies, functional and mechanical performance testing, simulated distribution testing, and analytical support for products such as auto-injectors, prefilled syringes, inhalers, and other drug-device combination products.

With her extensive expertise in analytical services and regulatory testing, Riter is expected to play a key role in advancing DDL's service portfolio and supporting customers in meeting increasingly complex pharmaceutical and medical device regulatory requirements.